Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed details of loss of share certificates/request for issue of duplicate share certificate reported by shareholder(s) of the Company, received from its Registrar and Transfer Agent, Link Intime India on September 21, 2023.
The above information is a part of company’s filings submitted to BSE.